In a global phase III trial, the addition of durvalumab (Imfinzi) to standard chemotherapy given before and after surgery led ...

Kezar Life Sciences (KZR) announced regulatory updates and the initiation of a process to explore a full range of strategic alternatives focused ...

The University of Arizona Faculty Senate voted Monday to reject the White House’s Compact for Academic Excellence, citing ...

A common painkiller taken by millions could have cancer fighting properties, slashing the risk of womb, bowel, lung and ...

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...